Misomife-Femi Combo is indicated for early medical abortion up to 9 weeks (63 days) of pregnancy.
Each combo pack contains:
1 Mifepristone tablet (A)
4 Misoprostol tablets (B)
(A) Mifepristone Tablet – 200 mg
Each uncoated tablet contains:
Mifepristone – 200 mg
Excipients – q.s. (quantum satis / sufficient quantity)
(B) Misoprostol Tablet – 200 mcg
Each uncoated tablet contains:
Misoprostol – 200 mcg
Excipients – q.s. (sufficient quantity)
Misomife-Femi Combo is indicated for early medical termination of pregnancy up to 9 weeks (63 days) of gestation.
The dose of mifepristone is 200 mg orally, followed 1 to 3 days later by 800 mcg of misoprostol (4 tablets of 200 mcg) taken orally. Administration of misoprostol may be assisted by a healthcare provider.
For women between 49 and 63 days of pregnancy, if abortion has not occurred within 4 hours of taking misoprostol, an additional dose of 400 mcg (two 200 mcg tablets) may be administered orally.
The patient should return for a follow-up visit approximately 14 days after taking mifepristone. This follow-up is crucial to confirm complete termination of the pregnancy through clinical assessment or ultrasound.
Any intrauterine device (IUD) must be removed prior to initiating treatment with mifepristone and misoprostol.
Surgical abortion is recommended in cases where intrauterine pregnancy is not terminated with Misomife-Femi Combo.
Pediatric population:
The use of this medication has not been evaluated in children or adolescents.
Mifepristone and misoprostol are contraindicated in women seeking medical abortion who have any of the following conditions:
Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass
Pregnancy duration beyond 63 days of amenorrhea
Presence of an IUD (intrauterine device)
Chronic adrenal failure
Long-term corticosteroid therapy
Known hypersensitivity to mifepristone, misoprostol, or other prostaglandins
Hemorrhagic disorders or concurrent anticoagulant therapy
Inherited porphyria
Lack of access to appropriate medical care facilities for emergency management of incomplete abortion
Store below 25°C.
Keep out of reach of children.
Not intended for use in children.
